Checkmate 901
concept
2 mentions
1 recordings
first heard Oct 2024
last heard Oct 2024
±0 this month
Phase III trial combining nivolumab with chemotherapy (CheckMate‑901)
Trend
No mentions in the last 30d.Widen the range to see when Checkmate 901 was said.
Moments
newest first · ▶ plays the momentDr. Andrea ApoloBackTable Urology · Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights wit... · 4:24 · Oct 2024
…ongoing right now, and Niagara was the first one to report its outcome. And, you know, once I saw that the Checkmate 901 study was positive, that adding nivolumab actually did improve outcomes to platinum-based chemotherapy, but to cisplatinum-based chemotherapy, it didn't have as strong effect with carboplatinum. So that was...…
Dr. Andrea ApoloBackTable Urology · Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights wit... · 3:55 · Oct 2024
…Yeah, so I was so excited to see the results of this study, especially after last year, we saw the really exciting results of EV plus PEMBRO in the metastatic setting. And then we saw the Checkmate 901 data, where when nivolumab was added to GEMSYS, it did better than just GEMSYS alone. And that just kind of set the stage for the perioperative trials that a…
All 2 moments